License-in (originals)
Women’s Health
| Territory: | European Union (EU), Russia and Commonwealth of Independent States (CIS), China, Latin-America, Australia |
| We are searching for: | clinical phase projects with at least an efficacy signal, registered or marketed products |
| We offer: | co-development and co-financing, registration, participation in P&R approval, sales and marketing |
Central Nervous System
| Territory: |
Global |
|
We are searching for: |
research phase projects for treatment of general negative symptoms (e.g. schizophrenia negative symptoms, bipolar and major depression), treatment of psychotic symptoms (e.g. bipolar disorder) and treatment of cognitive symptoms (e.g. CIAS) |
|
We offer: |
acquisition of early developments, co-development and co-financing, registration, participation in P&R approval, sales and marketing |
Other therapy areas (Cardiovascular, Rheumatology, Respiratory, Anti-infectives, CNS late phase), OTC products
|
Territory: |
Central and Eastern Europe (CEE), Russia and Commonwealth of Independent States (CIS), China |
|
We are searching for: |
late-stage clinical phase projects, registered or marketed products |
|
We offer: |
co-financing, registration, participation in P&R approval, sales and marketing |
Joint development
We offer early Research and Development collaborations targeting the symptomatic treatment of general negative, psychotic and cognitive symptoms of psychiatric disorders and participation in the design and running of clinical trials in strategically selected areas within the Central Nervous System and Gynecology.
Technology transfer & manufacturing
With the ability to manufacture a broad range of finished dosage forms in state of the art EMA and FDA approved facilities in Hungary, Poland, Romania, Russia and Germany Richter is open to discuss manufacturing opportunities of innovative license-in projects. Richter is also actively searching for contract manufacturing opportunities for his state-of-the-art manufacturing facilities with a special emphasis on contract development and manufacturing of steroid APIs and finished dosage forms.
